MetrionAIIntelligence

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Lunai Bioworks Inc.

LNAI

HealthcareNASDAQUS

$2.45

-$0.47 (-16.10%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

LNAI

1Y-0.47 (-16.10%)

Candles, volume, SMA 20, and SMA 50

O 2.76H 2.9L 2.45C 2.45Date Jun 5

LNAI

SMA 20 SMA 50 Vol 48.95KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$11.11M

Volume?47.42K

Avg Volume?2.69M

52w Range$1.208 - $33.52

Beta?0.36

Price Performance

-7.9%

$2.66 to $2.45

YTD

-65.2%

$7.05 to $2.45

N/A

history unavailable

N/A

history unavailable

N/A

history unavailable

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEODavid H. Weinstein

IndustryBiotechnology

Employees29

IPO Date2025-09-30

CurrencyUSD

Websitehttp://www.renovarogroup.com

Related stocks

Check out other names from the same Biotechnology industry as LNAI.

ADAP-

Adaptimmune Therapeutics plc

Ernexa Therapeutics Inc.

SeaStar Medical Holding Corporation

Moleculin Biotech, Inc.